39 related articles for article (PubMed ID: 21155598)
1. Evaluation of Protein Purification Techniques and Effects of Storage Duration on LC-MS/MS Analysis of Archived FFPE Human CRC Tissues.
Rossouw SC; Bendou H; Blignaut RJ; Bell L; Rigby J; Christoffels A
Pathol Oncol Res; 2021; 27():622855. PubMed ID: 34257588
[TBL] [Abstract][Full Text] [Related]
2. Biomarker Analysis of Formalin-Fixed Paraffin-Embedded Clinical Tissues Using Proteomics.
Obi EN; Tellock DA; Thomas GJ; Veenstra TD
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671481
[TBL] [Abstract][Full Text] [Related]
3. Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis.
Zhu C; Hu H; Li J; Wang J; Wang K; Sun J
World J Surg Oncol; 2020 Mar; 18(1):52. PubMed ID: 32156290
[TBL] [Abstract][Full Text] [Related]
4. Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
Serna G; Ruiz-Pace F; Cecchi F; Fasani R; Jimenez J; Thyparambil S; Landolfi S; Elez E; Vivancos A; Hembrough T; Tabernero J; Dienstmann R; Nuciforo P
Sci Rep; 2019 Sep; 9(1):13568. PubMed ID: 31537838
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.
Pedersen MH; Hood BL; Beck HC; Conrads TP; Ditzel HJ; Leth-Larsen R
Oncoimmunology; 2017; 6(5):e1305531. PubMed ID: 28638726
[TBL] [Abstract][Full Text] [Related]
6. Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.
Tachtsidis A; McInnes LM; Jacobsen N; Thompson EW; Saunders CM
Clin Exp Metastasis; 2016 Aug; 33(6):521-50. PubMed ID: 27189371
[TBL] [Abstract][Full Text] [Related]
7. Quantification of HER family receptors in breast cancer.
Nuciforo P; Radosevic-Robin N; Ng T; Scaltriti M
Breast Cancer Res; 2015 Apr; 17():53. PubMed ID: 25887735
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and metabolic prediction of response to therapy in gastric cancer.
Aichler M; Luber B; Lordick F; Walch A
World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
[TBL] [Abstract][Full Text] [Related]
9. Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.
Al-Ejeh F; Miranda M; Shi W; Simpson PT; Song S; Vargas AC; Saunus JM; Smart CE; Mariasegaram M; Wiegmans AP; Chenevix-Trench G; Lakhani SR; Khanna KK
Oncotarget; 2014 May; 5(10):3145-58. PubMed ID: 24762669
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of nuclei dissected from fixed rat brain tissue using expression microdissection.
Blackler AR; Morgan NY; Gao B; Olano LR; Armani MD; Romantseva E; Kakareka JW; Bonner RF; Mukherjee S; Xiao B; Tran K; Pohida TJ; Emmert-Buck MR; Tangrea MA; Markey SP
Anal Chem; 2013 Aug; 85(15):7139-45. PubMed ID: 23799655
[TBL] [Abstract][Full Text] [Related]
11. Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
Hembrough T; Thyparambil S; Liao WL; Darfler MM; Abdo J; Bengali KM; Taylor P; Tong J; Lara-Guerra H; Waddell TK; Moran MF; Tsao MS; Krizman DB; Burrows J
Clin Proteomics; 2012 May; 9(1):5. PubMed ID: 22554165
[TBL] [Abstract][Full Text] [Related]
12. Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues.
Magdeldin S; Yamamoto T
Proteomics; 2012 Apr; 12(7):1045-58. PubMed ID: 22318899
[TBL] [Abstract][Full Text] [Related]
13. Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse.
Imielinski M; Cha S; Rejtar T; Richardson EA; Karger BL; Sgroi DC
Mol Cell Proteomics; 2012 Jun; 11(6):M111.014910. PubMed ID: 22240506
[TBL] [Abstract][Full Text] [Related]
14. Proteomics and biomarkers in clinical trials for drug development.
Lee JM; Han JJ; Altwerger G; Kohn EC
J Proteomics; 2011 Nov; 74(12):2632-41. PubMed ID: 21570499
[TBL] [Abstract][Full Text] [Related]
15. Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues.
Bateman NW; Sun M; Bhargava R; Hood BL; Darfler MM; Kovatich AJ; Hooke JA; Krizman DB; Conrads TP
J Proteome Res; 2011 Mar; 10(3):1323-32. PubMed ID: 21155598
[TBL] [Abstract][Full Text] [Related]
16. Unravelling the proteome of formalin-fixed paraffin-embedded tissue.
Hood BL; Conrads TP; Veenstra TD
Brief Funct Genomic Proteomic; 2006 Jun; 5(2):169-75. PubMed ID: 16772271
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within.
Hood BL; Conrads TP; Veenstra TD
Proteomics; 2006 Jul; 6(14):4106-14. PubMed ID: 16800036
[TBL] [Abstract][Full Text] [Related]
18. Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens.
Guo T; Wang W; Rudnick PA; Song T; Li J; Zhuang Z; Weil RJ; DeVoe DL; Lee CS; Balgley BM
J Histochem Cytochem; 2007 Jul; 55(7):763-72. PubMed ID: 17409379
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma.
Negishi A; Masuda M; Ono M; Honda K; Shitashige M; Satow R; Sakuma T; Kuwabara H; Nakanishi Y; Kanai Y; Omura K; Hirohashi S; Yamada T
Cancer Sci; 2009 Sep; 100(9):1605-11. PubMed ID: 19522851
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
